Workflow
敏芯股份
icon
Search documents
敏芯股份:9月25日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-09-25 12:09
Group 1 - The company Minxin Co., Ltd. announced on September 25 that its fourth board meeting will be held in a combined format of on-site and remote voting [1] - The meeting will review the proposal regarding the adjustment of the members of the company's fourth board specialized committee [1] Group 2 - On the anniversary of the "9.24" event, the total market value of A-shares has surpassed 116 trillion yuan, indicating significant changes in the Chinese capital market [1]
恒瑞医药签署瑞康曲妥珠单抗授权许可,最高可获近11美元丨公告精选
Group 1 - Guoxin Technology announced that four shareholders plan to reduce their holdings by a total of no more than 4.5% of the company's shares, with specific reductions including 8.5 million shares from Tibet Jinsong Taida Venture Capital, accounting for 2.53% of total shares [1] - Shengke Communication reported that the National Integrated Circuit Industry Investment Fund reduced its shareholding from 19.60% to 15.00% by selling 18.8569 million shares [1] - Heng Rui Pharmaceutical signed a licensing agreement for its innovative drug SHR-A1811, receiving an upfront payment of $18 million and being eligible for up to $1.093 billion in milestone payments [1] Group 2 - Shangwei New Materials announced that its affiliate Zhiyuan Hengyue plans to make a tender offer to acquire 37% of the company's shares at a price of 7.78 yuan per share, with a maximum funding requirement of 1.161 billion yuan [2] - Huasoft Technology stated that it is currently producing and selling light-initiated agents in small batches based on customer orders, with revenue from this product expected to account for less than 2% of total revenue in 2024 [3] - Tian Shili's subsidiary received approval for clinical trials of TSL2109 capsules, a dual-target drug for advanced solid tumors, with no similar drugs currently in clinical trials [3] Group 3 - Dalong Real Estate announced plans to acquire 60% of Beijing Chengzhu Real Estate Development Co., with the transaction still in the planning stage and not yet confirmed as a related party transaction [4][5] - Xizang Tourism decided to terminate its major asset restructuring plan to acquire a 60% stake in Beihai Xinyi Cruise Co., due to market environment changes [6] - Jingzhida delivered its first high-speed testing machine for semiconductor memory testing, which is expected to positively impact future operating performance [7] Group 4 - Hongsheng Huayuan elected Ma Xinzhen as the chairman of the board, who will also serve as the head of the strategic committee [8] - Wanhui High-tech expects a net profit increase of 69.81% to 109.77% year-on-year for the first three quarters [10] - New Zhizhi Software's subsidiary plans to acquire 49% of Shenzhen Hengdao's shares [10]
敏芯股份:股东询价转让定价情况提示性公告
证券日报网讯 9月24日晚间,敏芯股份发布公告称,根据2025年9月24日询价申购情况,初步确定的本 次询价转让价格为88.99元/股。受让方通过询价转让受让的股份,在受让后6个月内不得转让。 (编辑 楚丽君) ...
敏芯股份(688286) - 苏州敏芯微电子技术股份有限公司股东询价转让定价情况提示性公告
2025-09-24 10:33
证券代码:688286 证券简称:敏芯股份 公告编号:2025-054 苏州敏芯微电子技术股份有限公司 股东询价转让定价情况提示性公告 苏州昶众企业管理咨询中心(有限合伙)、苏州昶恒企业管理咨询企业(有 限合伙)(以上股东合称"出让方")保证向苏州敏芯微电子技术股份有限公司(以 下简称"敏芯股份"、"公司")提供的信息内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其真实性、准确性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: 根据 2025 年 9 月 24 日询价申购情况,初步确定的本次询价转让价格为 88.99 元/股。 受让方通过询价转让受让的股份,在受让后 6 个月内不得转让。 一、本次询价转让初步定价 (一)经向机构投资者询价后,初步确定的转让价格为 88.99 元/股。 (二)参与本次询价转让报价的机构投资者家数为 12 家,涵盖了基金管理 公司、合格境外机构投资者、证券公司、私募基金管理人等专业机构投资者。 (三)本次询价转让拟转让股份已获全额认购,初步确定受让方为 8 家机构 投资者,拟受让股份总数为 960,223 股。 ...
敏芯股份(688286.SH):初步确定询价转让价格为88.99元/股
智通财经网· 2025-09-24 10:32
Core Viewpoint - Minxin Co., Ltd. (688286.SH) has disclosed the pricing situation for a shareholder inquiry transfer, with a preliminary transfer price set at 88.99 CNY per share based on the inquiry subscription situation as of September 24, 2025 [1] Group 1 - The total number of shares to be transferred is 960,223 shares, which have been fully subscribed [1] - The preliminary determined transferees are eight institutional investors [1] - The transferees are prohibited from transferring the acquired shares within six months after the transfer [1]
敏芯股份:初步确定询价转让价格为88.99元/股
南财智讯9月24日电,敏芯股份公告,根据2025年9月24日的询价申购情况,初步确定的询价转让价格为 88.99元/股。本次询价转让的参与机构投资者共12家,涵盖基金管理公司、合格境外机构投资者、证券 公司、私募基金管理人等,初步确定受让方为8家机构投资者,拟受让股份总数为96.0223万股。受让方 在受让后6个月内不得转让。本次询价转让不涉及公司控制权变更,不会影响公司治理结构和持续经 营。 ...
苏州敏芯微电子技术股份有限公司股东询价转让计划书
Core Viewpoint - The shareholders of Suzhou Minxin Microelectronics Technology Co., Ltd. plan to transfer a total of 960,223 shares, representing 1.71% of the company's total share capital, through a non-public inquiry transfer to institutional investors due to their own funding needs [3][7]. Group 1: Shareholder Transfer Details - The shareholders involved in the transfer are Suzhou Changzhong Enterprise Management Consulting Center (Limited Partnership) and Suzhou Changheng Enterprise Management Consulting Company (Limited Partnership) [3][4]. - The transfer will not occur through centralized bidding or block trading and is not considered a reduction through the secondary market [3][7]. - The shares to be transferred have been released from restrictions, and the transferors confirm that there are no limitations or prohibitions on the transfer [5][11]. Group 2: Transfer Pricing and Conditions - The minimum transfer price will not be lower than 70% of the average stock price over the 20 trading days prior to September 23, 2025 [8]. - If the total number of valid subscriptions exceeds the number of shares available for transfer, the transfer price will be determined based on price priority, quantity priority, and time priority [9]. - The transfer is open to institutional investors with appropriate pricing capabilities and risk tolerance, including various types of financial institutions [10]. Group 3: Company Status and Risks - Suzhou Minxin Microelectronics does not face any operational risks that require disclosure under the relevant stock exchange rules [11]. - The inquiry transfer does not pose a risk of control change for the company [11]. - There are no other undisclosed significant matters related to the company [11].
甘李药业签订不低于30亿元甘精胰岛素相关供应框架协议丨公告精选
Group 1: Company Announcements - Ganli Pharmaceutical signed a technology transfer and supply agreement with FZ and BIOMM, with a total supply framework agreement amount expected to be no less than 3 billion RMB [1] - Upwind New Materials completed the transfer of 121 million shares, changing its controlling shareholder to Zhiyuan Hengyue, associated with Zhiyuan Robotics [2] - Poly Developments plans to publicly issue corporate bonds not exceeding 15 billion RMB for various purposes including debt repayment and project construction [3] Group 2: Shareholder Actions - Lenovo Holdings reduced its stake in Lakala by 8.0781 million shares, decreasing its ownership from 25.00% to 23.97% [4] - Fenghuo Communication plans to repurchase shares with a budget between 75 million and 150 million RMB, with a maximum repurchase price of 40.53 RMB per share [5] - Hualing Cable intends to acquire control of San Bamboo Intelligent for no more than 270 million RMB to enhance its capabilities in robotics and high-frequency transmission [6] Group 3: Market Developments - Guiguang Network clarified that rumors regarding major collaborations with Huawei Cloud and restructuring with state-owned enterprises are untrue [7] - Dongshan Precision is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international presence [8] - Wolong Nuclear Materials' subsidiary plans to invest up to 1 billion RMB in a new materials project in Suzhou [9] Group 4: Other Corporate Activities - Chao Xun Communication's management completed their share reduction plan, with specific shares sold by board members [10] - Various companies are involved in significant project bids and collaborations, including China Electric Research and others [15]
敏芯股份(688286.SH)股东拟询价转让1.71%股份
智通财经网· 2025-09-23 10:54
Core Viewpoint - Minxin Co., Ltd. (688286.SH) has disclosed a shareholder inquiry transfer plan, indicating a potential change in ownership structure [1] Group 1: Shareholder Transfer Details - The shareholders involved in the inquiry transfer are Suzhou Changzhong Enterprise Management Consulting Center (Limited Partnership) and Suzhou Changheng Enterprise Management Consulting Company (Limited Partnership) [1] - The total number of shares to be transferred is 960,223 shares, which represents 1.71% of the company's total share capital [1]
敏芯股份股东拟询价转让1.71%股份
Zhi Tong Cai Jing· 2025-09-23 10:51
Group 1 - The core point of the article is that Minxin Co., Ltd. (688286.SH) has disclosed a share transfer plan involving a total of 960,223 shares, which represents 1.71% of the company's total equity [1] Group 2 - The shareholders participating in the transfer are Suzhou Changzhong Enterprise Management Consulting Center (Limited Partnership) and Suzhou Changheng Enterprise Management Consulting Company (Limited Partnership) [1]